Cargando…
Evaluation of Microbial-Fructo-Oligosaccharides Metabolism by Human Gut Microbiota Fermentation as Compared to Commercial Inulin-Derived Oligosaccharides
The prebiotic potential of fructo-oligosaccharides (microbial-FOS) produced by a newly isolated Aspergillus ibericus, and purified by Saccharomyces cerevisiae YIL162 W, was evaluated. Their chemical structure and functionality were compared to a non-microbial commercial FOS sample. Prebiotics were f...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997964/ https://www.ncbi.nlm.nih.gov/pubmed/35407041 http://dx.doi.org/10.3390/foods11070954 |
_version_ | 1784684829314383872 |
---|---|
author | Roupar, Dalila Coelho, Marta C. Gonçalves, Daniela A. Silva, Soraia P. Coelho, Elisabete Silva, Sara Coimbra, Manuel A. Pintado, Manuela Teixeira, José A. Nobre, Clarisse |
author_facet | Roupar, Dalila Coelho, Marta C. Gonçalves, Daniela A. Silva, Soraia P. Coelho, Elisabete Silva, Sara Coimbra, Manuel A. Pintado, Manuela Teixeira, José A. Nobre, Clarisse |
author_sort | Roupar, Dalila |
collection | PubMed |
description | The prebiotic potential of fructo-oligosaccharides (microbial-FOS) produced by a newly isolated Aspergillus ibericus, and purified by Saccharomyces cerevisiae YIL162 W, was evaluated. Their chemical structure and functionality were compared to a non-microbial commercial FOS sample. Prebiotics were fermented in vitro by fecal microbiota of five healthy volunteers. Microbial-FOS significantly stimulated the growth of Bifidobacterium probiotic strains, triggering a beneficial effect on gut microbiota composition. A higher amount of total short-chain fatty acids (SCFA) was produced by microbial-FOS fermentation as compared to commercial-FOS, particularly propionate and butyrate. Inulin neoseries oligosaccharides, with a degree of polymerization (DP) up to 5 (e.g., neokestose and neonystose), were identified only in the microbial-FOS mixture. More than 10% of the microbial-oligosaccharides showed a DP higher than 5. Differences identified in the structures of the FOS samples may explain their different functionalities. Results indicate that microbial-FOS exhibit promising potential as nutraceutical ingredients for positive gut microbiota modulation. |
format | Online Article Text |
id | pubmed-8997964 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89979642022-04-12 Evaluation of Microbial-Fructo-Oligosaccharides Metabolism by Human Gut Microbiota Fermentation as Compared to Commercial Inulin-Derived Oligosaccharides Roupar, Dalila Coelho, Marta C. Gonçalves, Daniela A. Silva, Soraia P. Coelho, Elisabete Silva, Sara Coimbra, Manuel A. Pintado, Manuela Teixeira, José A. Nobre, Clarisse Foods Article The prebiotic potential of fructo-oligosaccharides (microbial-FOS) produced by a newly isolated Aspergillus ibericus, and purified by Saccharomyces cerevisiae YIL162 W, was evaluated. Their chemical structure and functionality were compared to a non-microbial commercial FOS sample. Prebiotics were fermented in vitro by fecal microbiota of five healthy volunteers. Microbial-FOS significantly stimulated the growth of Bifidobacterium probiotic strains, triggering a beneficial effect on gut microbiota composition. A higher amount of total short-chain fatty acids (SCFA) was produced by microbial-FOS fermentation as compared to commercial-FOS, particularly propionate and butyrate. Inulin neoseries oligosaccharides, with a degree of polymerization (DP) up to 5 (e.g., neokestose and neonystose), were identified only in the microbial-FOS mixture. More than 10% of the microbial-oligosaccharides showed a DP higher than 5. Differences identified in the structures of the FOS samples may explain their different functionalities. Results indicate that microbial-FOS exhibit promising potential as nutraceutical ingredients for positive gut microbiota modulation. MDPI 2022-03-25 /pmc/articles/PMC8997964/ /pubmed/35407041 http://dx.doi.org/10.3390/foods11070954 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Roupar, Dalila Coelho, Marta C. Gonçalves, Daniela A. Silva, Soraia P. Coelho, Elisabete Silva, Sara Coimbra, Manuel A. Pintado, Manuela Teixeira, José A. Nobre, Clarisse Evaluation of Microbial-Fructo-Oligosaccharides Metabolism by Human Gut Microbiota Fermentation as Compared to Commercial Inulin-Derived Oligosaccharides |
title | Evaluation of Microbial-Fructo-Oligosaccharides Metabolism by Human Gut Microbiota Fermentation as Compared to Commercial Inulin-Derived Oligosaccharides |
title_full | Evaluation of Microbial-Fructo-Oligosaccharides Metabolism by Human Gut Microbiota Fermentation as Compared to Commercial Inulin-Derived Oligosaccharides |
title_fullStr | Evaluation of Microbial-Fructo-Oligosaccharides Metabolism by Human Gut Microbiota Fermentation as Compared to Commercial Inulin-Derived Oligosaccharides |
title_full_unstemmed | Evaluation of Microbial-Fructo-Oligosaccharides Metabolism by Human Gut Microbiota Fermentation as Compared to Commercial Inulin-Derived Oligosaccharides |
title_short | Evaluation of Microbial-Fructo-Oligosaccharides Metabolism by Human Gut Microbiota Fermentation as Compared to Commercial Inulin-Derived Oligosaccharides |
title_sort | evaluation of microbial-fructo-oligosaccharides metabolism by human gut microbiota fermentation as compared to commercial inulin-derived oligosaccharides |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997964/ https://www.ncbi.nlm.nih.gov/pubmed/35407041 http://dx.doi.org/10.3390/foods11070954 |
work_keys_str_mv | AT roupardalila evaluationofmicrobialfructooligosaccharidesmetabolismbyhumangutmicrobiotafermentationascomparedtocommercialinulinderivedoligosaccharides AT coelhomartac evaluationofmicrobialfructooligosaccharidesmetabolismbyhumangutmicrobiotafermentationascomparedtocommercialinulinderivedoligosaccharides AT goncalvesdanielaa evaluationofmicrobialfructooligosaccharidesmetabolismbyhumangutmicrobiotafermentationascomparedtocommercialinulinderivedoligosaccharides AT silvasoraiap evaluationofmicrobialfructooligosaccharidesmetabolismbyhumangutmicrobiotafermentationascomparedtocommercialinulinderivedoligosaccharides AT coelhoelisabete evaluationofmicrobialfructooligosaccharidesmetabolismbyhumangutmicrobiotafermentationascomparedtocommercialinulinderivedoligosaccharides AT silvasara evaluationofmicrobialfructooligosaccharidesmetabolismbyhumangutmicrobiotafermentationascomparedtocommercialinulinderivedoligosaccharides AT coimbramanuela evaluationofmicrobialfructooligosaccharidesmetabolismbyhumangutmicrobiotafermentationascomparedtocommercialinulinderivedoligosaccharides AT pintadomanuela evaluationofmicrobialfructooligosaccharidesmetabolismbyhumangutmicrobiotafermentationascomparedtocommercialinulinderivedoligosaccharides AT teixeirajosea evaluationofmicrobialfructooligosaccharidesmetabolismbyhumangutmicrobiotafermentationascomparedtocommercialinulinderivedoligosaccharides AT nobreclarisse evaluationofmicrobialfructooligosaccharidesmetabolismbyhumangutmicrobiotafermentationascomparedtocommercialinulinderivedoligosaccharides |